About the role:
Our Manufacturing Development team’s mission is to develop, de-risk, scale, and continuously improve robust manufacturing processes that enable reliable delivery of the nELISA platform. The team operates at the intersection of engineering, assay development, automation, QC, and operations, with a focus on translating scientific and technical workflows into scalable, reproducible, and manufacturing-ready processes.
As a Senior Scientist, Manufacturing Development, you will provide technical leadership to define, develop and enhance the processes that drive our platform’s scalability and performance. Based at our Montréal, QC facility, this role blends deep scientific and engineering expertise with hands‑on bench work, cross‑functional collaboration and data‑driven planning. You’ll spearhead complex initiatives to improve assay performance, process robustness, throughput, reliability and the smooth transfer of workflows into routine operations.
- Drive complex manufacturing‑development initiatives and help define the technical roadmap — covering process robustness, assay performance, automation readiness, kit manufacturing, QC architecture, scalability, and transfer readiness.
- Convert ambiguous manufacturing or assay requirements into structured experimental and validation plans, and design/run campaigns using DoE, process characterization, robustness testing, FMEA and scale‑up/down approaches.
- Design and develop robust QC strategies (in‑process controls, lot‑to‑lot consistency, trend analysis and pass/fail decision frameworks) and lead cross‑functional root‑cause investigations.
- Deliver stellar communication and collaboration across R&D, Operations, Automation, Quality teams; maintain meticulous documentation and share data‑driven reports, insights and memos to align stakeholders and ensure development outputs are both scientifically sound and operationally ready for transfer.
- Independently analyze and interpret complex datasets by combining assay performance, process parameters, QC trends and operational metrics, and translate into actionable technical recommendations and continuous‑improvement initiatives that enhance reproducibility, stability, throughput and compliance.
- Mentor scientists and associates, providing technical guidance on experimental design, troubleshooting, data interpretation, automation‑aware process development, QC thinking and kit‑manufacturing best practices.
What we’re looking for:
- PhD or Master’s in bioengineering, biotechnology, biochemistry or a related field with at least five years of industry experience working in wet‑lab environments.
- Deep expertise in protein quantification and immunoassay methods (ELISA, sandwich assays, flow cytometry, bead‑based assays), kit development, QC under GMP/GLP standards, and a strong foundation in genomics, transcriptomics and proteomics technologies.
- Proven ability to design, lead and scale complex experiments and process development projects (e.g. assay optimization, process characterization, robustness and validation studies), including tech transfer and compliance to regulated environments.
- Hands‑on experience with automation‑enabled workflows and instrumentation (liquid handlers, plate readers, washers, dispensers, imaging systems), coupled with strong data analysis (Python or equivalent) and scientific judgement to translate complex assay behaviour into practical, scalable and controlled workflows.
- Demonstrated leadership in mentoring and developing junior scientists, and comfort operating in fast‑paced, evolving environments where scientific ambiguity, operational constraints and scaling needs must be balanced thoughtfully.
- Strong English communication skills for collaborating with U.S.‑based teams, partners and vendors.
Join us if you:
- Connect deeply with our mission, ambition and sense of duty. Our mission isn’t marketing flash: we developed our technology to better measure biology and discover biomarkers for early disease detection. We firmly believe we will be successful in literally eradicating certain diseases by enabling them to be diagnosed earlier. We also believe that our hard work to bring this technology to its full potential is our duty.
- Are up for a challenge and want to grow: We are a team of problem-solvers, and we continually put ourselves to the test and go into the unknown. We have a growth mindset, both on hard and soft skills, and we rely on each other to give critical and candid feedback to ensure that we can all reach our full potential.
- Want to be at the cutting-edge of biotechnology. The nELISA is a new tool that leverages DNA nanotechnology to generate proteomic data more efficiently than ever before. You get to design and build the data pipelines and analysis tools that will support the scaling of this technology going forward.
- You have a genuine passion for manufacturing and end‑to‑end product delivery — the idea of refining every step, from reagents and kit assembly to packaging and logistics, excites you and drives you to ensure each link in the chain meets the highest standards.
- Prefer working and communicating within a diverse cross-functional team. You would get to interface with teammates from the Engineering, Operations, and Commercial teams on a daily basis, joining a collaborative, diverse, and inclusive team where your ideas will be valued.
If you are passionate about lab work and solving ambiguous technical challenges, want to drive innovation in proteomics, and are eager to make a meaningful impact in the world, we invite you to apply and join us on our journey to redefine proteomics and the understanding of biology.
About Nomic
Nomic was founded to make biology easier to measure—and to enable scientists to extend lives by making proteomics accessible, scalable, and routine. Our story began at McGill University, where our co-founders and early team developed breakthrough technology that would change the way proteins are measured.
Today, Nomic is powered by our proprietary nELISA® platform—an end-to-end technology that delivers high-throughput, quantitative, and affordable protein data at unprecedented scale. With the launch of Omni 1000, we are making the $50 proteome a reality, breaking down barriers that have limited the field for decades. For the first time, large-scale, quantitative proteomics is accessible to any scientist, supporting everything from drug discovery and translational research to AI-enabled therapeutic development.
Since our launch, we’ve partnered with leaders in pharma, biotech, and academia—including GlaxoSmithKline and the Broad Institute—and have profiled more than 500,000 samples across diverse applications. Our growth is fueled by over $60 million in investment from top-tier backers, including our recent $42 million Series B.
We’re building a team of world-changers—scientists, engineers, and problem-solvers who believe that accessible proteomics can help shape the future of medicine. If you want your work to have real impact, we’d love to meet you.
Learn more in our Series B announcement.
